Live
- DEO suspends teacher accused of sexual assault
- PM ‘cursing’ Congress out of despair: Maharashtra Cong Chief
- Applications are invited for Junior Colleges Scheme District Scheduled Castes Development Officer Ramlal
- A nomination was filed on the second day for the Nagar Kurnool parliamentary seat
- SP Gaikwad inspected the Telangana Amarnath Saleswaram Jatara yatra arrangements
- Rahul Gandhi's decision to contest from Wayanad shows 'lack of confidence': BJP President Nadda
- IPL 2024: Delhi bowlers will go after all of SRH’s top-order batters, says head coach Ricky Ponting
- At Amroha rally, PM Modi sends out ‘meaningful’ message for Muslims and Hindus
- Tripura records highest 79.83 pc voter turnout in Northeast
- The government has to clear the confusion
Indian origin scientist at MIT develops Artificial liver, earns Heinz award
Highlights
An Indian-origin scientist at MIT, who has developed artificial human microlivers for drug testing, has won a prestigious $250,000 Heinz award for her work in tissue engineering and disease detection.
An Indian-origin scientist at MIT, who has developed artificial human microlivers for drug testing, has won a prestigious $250,000 Heinz award for her work in tissue engineering and disease detection.
.jpg)
Sangeeta Bhatia at the Massachusetts Institute of Technology has been named the recipient of the 2015 Heinz Award. The Heinz Awards annually recognise individuals for their extraordinary contributions to arts and humanities; environment; human condition; public policy; and technology, the economy, and employment.
The Heinz Awards annually recognise individuals for their extraordinary contributions to arts and humanities; environment; human condition; public policy; and technology, the economy, and employment. “This type of recognition helps to bring science into the public eye so that everyone can appreciate the dedication and innovation that is happening in laboratories all over the country,” said Bhatia.
Bhatia’s team has pioneered the fabrication of artificial human microlivers, which are being used by many biopharmaceutical companies to test the toxicity of drug candidates. She is also using microlivers in the lab to model malaria infection and test drugs that can eradicate malaria parasites completely - even the parasite reservoirs that remain in the liver after a patient’s symptoms subside.
Next Story
ADVERTISEMENT
